science
CDC vaccine panel charter revised to broaden member criteria and review alternatives
A new charter for the Advisory Committee on Immunization Practices posted June 25, 2026, broadens expertise requirements and adds responsibility to assess non-vaccine prevention options. The document replaces a March version deemed invalid and follows a court ruling that most current members lack required qualifications.
nbcnews.comAudio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
The Centers for Disease Control and Prevention posted a revised charter for its Advisory Committee on Immunization Practices on June 25, 2026. The document broadens the criteria for committee members and adds a requirement to evaluate alternatives to vaccines for disease prevention.
Previous versions of the charter emphasized vaccine research experience when selecting members. The new text states only that the panel as a whole should represent a balanced range of scientific, clinical, and public health expertise relevant to the committee’s mission.
Court challenge and prior ruling A federal judge issued a preliminary ruling that most current members lack the qualifications specified in earlier charter language. The administration has appealed that decision. The committee has not met in 2026. The suit remains active.
On June 25, the parties filed a status report with the presiding judge regarding which materials in the case should remain confidential.
Statements from observers Sara Rosenbaum, professor emerita of health law and policy at George Washington University’s Milken Institute School of Public Health, said the charter change followed the court’s finding that many appointments failed to meet prior criteria.
Paul Offit, a pediatrician and vaccine expert at Children’s Hospital of Philadelphia, said the revision appeared intended to allow the current members to qualify under the updated standards. Richard Hughes, the lawyer who filed the legal challenge on behalf of the American Academy of Pediatrics, said the new charter reduces explicit references to the committee’s prior focus while retaining changes to liaison representation and CDC oversight.
